Tivity Health Inc (NASDAQ:TVTY) – Equities researchers at Cantor Fitzgerald lowered their FY2020 earnings estimates for shares of Tivity Health in a research note issued on Thursday, August 8th. Cantor Fitzgerald analyst S. Halper now anticipates that the company will earn $2.65 per share for the year, down from their prior forecast of $2.73. Cantor Fitzgerald has a “Overweight” rating and a $45.00 price objective on the stock.

Tivity Health (NASDAQ:TVTY) last issued its earnings results on Wednesday, August 7th. The company reported $0.64 EPS for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.02). Tivity Health had a return on equity of 24.83% and a net margin of 8.88%. The firm had revenue of $340.40 million for the quarter, compared to analysts’ expectations of $340.73 million. During the same period last year, the firm earned $0.53 earnings per share. Tivity Health’s revenue for the quarter was up 124.1% on a year-over-year basis.

TVTY has been the topic of a number of other reports. Barrington Research reissued an “outperform” rating on shares of Tivity Health in a research note on Thursday, August 8th. Zacks Investment Research downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a research note on Friday, August 9th. Piper Jaffray Companies reduced their price target on shares of Tivity Health from $33.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, August 8th. Oppenheimer boosted their price target on shares of Tivity Health from $31.00 to $36.00 in a research note on Thursday, May 9th. Finally, BidaskClub raised shares of Tivity Health from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating to the company. Tivity Health has a consensus rating of “Buy” and an average target price of $32.11.

Shares of TVTY stock opened at $18.31 on Monday. The stock’s 50-day moving average price is $16.62. The stock has a market capitalization of $874.81 million, a P/E ratio of 7.82, a PEG ratio of 0.81 and a beta of 1.05. Tivity Health has a 12 month low of $14.84 and a 12 month high of $41.46. The company has a quick ratio of 0.76, a current ratio of 0.94 and a debt-to-equity ratio of 2.06.

Several hedge funds have recently made changes to their positions in the stock. Crestline Management LP purchased a new stake in shares of Tivity Health during the 2nd quarter worth approximately $1,586,000. BlackRock Inc. lifted its position in shares of Tivity Health by 4.8% during the 2nd quarter. BlackRock Inc. now owns 7,343,863 shares of the company’s stock worth $120,732,000 after buying an additional 337,571 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Tivity Health during the 2nd quarter worth approximately $2,851,000. Parametric Portfolio Associates LLC lifted its position in shares of Tivity Health by 133.9% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 410,012 shares of the company’s stock worth $6,741,000 after buying an additional 234,701 shares during the last quarter. Finally, Meadow Creek Investment Management LLC lifted its position in shares of Tivity Health by 22.8% during the 2nd quarter. Meadow Creek Investment Management LLC now owns 4,912 shares of the company’s stock worth $81,000 after buying an additional 912 shares during the last quarter.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Story: Why do corrections happen?

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.